Literature DB >> 23663310

Investigating highly replicated asthma genes as candidate genes for allergic rhinitis.

Anand Kumar Andiappan1, Daniel Nilsson, Christer Halldén, Wang De Yun, Torbjörn Säll, Lars Olaf Cardell, Chew Fook Tim.   

Abstract

BACKGROUND: Asthma genetics has been extensively studied and many genes have been associated with the development or severity of this disease. In contrast, the genetic basis of allergic rhinitis (AR) has not been evaluated as extensively. It is well known that asthma is closely related with AR since a large proportion of individuals with asthma also present symptoms of AR, and patients with AR have a 5-6 fold increased risk of developing asthma. Thus, the relevance of asthma candidate genes as predisposing factors for AR is worth investigating. The present study was designed to investigate if SNPs in highly replicated asthma genes are associated with the occurrence of AR.
METHODS: A total of 192 SNPs from 21 asthma candidate genes reported to be associated with asthma in 6 or more unrelated studies were genotyped in a Swedish population with 246 AR patients and 431 controls. Genotypes for 429 SNPs from the same set of genes were also extracted from a Singapore Chinese genome-wide dataset which consisted of 456 AR cases and 486 controls. All SNPs were subsequently analyzed for association with AR and their influence on allergic sensitization to common allergens.
RESULTS: A limited number of potential associations were observed and the overall pattern of P-values corresponds well to the expectations in the absence of an effect. However, in the tests of allele effects in the Chinese population the number of significant P-values exceeds the expectations. The strongest signals were found for SNPs in NPSR1 and CTLA4. In these genes, a total of nine SNPs showed P-values <0.001 with corresponding Q-values <0.05. In the NPSR1 gene some P-values were lower than the Bonferroni correction level. Reanalysis after elimination of all patients with asthmatic symptoms excluded asthma as a confounding factor in our results. Weaker indications were found for IL13 and GSTP1 with respect to sensitization to birch pollen in the Swedish population.
CONCLUSIONS: Genetic variation in the majority of the highly replicated asthma genes were not associated to AR in our populations which suggest that asthma and AR could have less in common than previously anticipated. However, NPSR1 and CTLA4 can be genetic links between AR and asthma and associations of polymorphisms in NPSR1 with AR have not been reported previously.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23663310      PMCID: PMC3653682          DOI: 10.1186/1471-2350-14-51

Source DB:  PubMed          Journal:  BMC Med Genet        ISSN: 1471-2350            Impact factor:   2.103


Background

Allergic rhinitis (AR) is a major chronic respiratory disease and the most common allergic disorder with a worldwide prevalence of 10-25% [1]. It has long been recognized that the development of AR is dependent on interactions between genetic and environmental factors and that the genetic factors play a major role with an estimated heritability for AR as high as 70-90% [2,3]. A large number of studies have identified more than 100 single nucleotide polymorphisms (SNPs) associated with AR, but few of them have been successfully replicated. The general reproducibility of a majority of these AR associations was found to be low in a previous study [4]. Only one genome-wide association study (GWAS) has been performed to identify genetic variants specifically for AR [5]. In that study, no associations were detected at a genome-wide significance level, and only two at a suggestive significance level. In addition, a genome-wide meta-analysis based on self-reported AR identified few genetic variants in spite of analyzing 2.2 million SNPs in close to 4000 AR cases and 9000 controls [6]. Only one locus reached genome-wide significance and six suggestive loci were identified. Comparing these two studies there were no significant association signals in common. In addition, no association signals of earlier linkage and candidate gene association studies coincide with any of the loci identified in the GWAS and the meta-study. This is not surprising, since the replication of different genotype-phenotype associations has in general proven to be much more difficult than initially appreciated [7]. Experience gathered in several different diseases indicates that there is a positive correlation between the ability to replicate previous associations and the size and number of previous studies. Thus, in diseases where many large previous association studies have been performed replication is often more successful. It is well known that asthma is closely related to AR since a large proportion of individuals with asthma also present symptoms of AR, and patients with AR have a 5–6 fold increased risk of developing asthma [8-10]. Asthma genetics has been extensively studied and many genes have been associated with the development or severity of this disease. Ober and Hoffjan (2006) listed 118 genes that had been reported to be associated with asthma or atopy-related phenotypes [11]. Of these genes, 25 were positively associated with asthma in six or more independent studies and were thus highly implicated as true susceptibility genes for asthma-related phenotypes. The original associations were identified in many different types of studies; linkage, positional cloning and candidate gene association studies and were subsequently replicated mostly by association studies. Several studies have investigated the reproducibility of asthma candidate gene associations. One study by Rogers et al. (2009) investigated 160 associated SNPs from 39 genes from an Illumina 550k array in 422 families and successfully replicated 10 SNPs in six genes [12]. At the level of the gene they found additional support for association in 15 of the 39 genes but none were significant after adjustment for multiple comparisons. In a consortium-based GWAS investigating 10,365 asthma patients with 16,110 controls a total of seven loci with genome-wide significance were identified [13]. None of the implicated genes overlapped with the genes identified in the study by Rogers et al. [12]. A meta-analysis of GWAS in ethnically diverse North American populations identified five susceptibility loci, four of whom at previously reported loci [14]. Also this study was very large and analyzed 5,416 patients with replication in 12,649 patients. The combined results of the many previous association studies for asthma illustrate the challenges in the search and replication of risk factors for asthma. Due to the close relationship between the occurrence of asthma and AR we hypothesize that these two phenotypes have genetic risk factors in common. The present study was thus designed to investigate if SNPs in highly replicated asthma genes as reported in the Ober and Hoffjan study [11] are associated with the occurrence of AR.

Methods

Subjects

The Swedish study population consists of 246 AR patients (108 female, 138 male) and 431 control individuals (185 female, 246 male) and was recruited from southern Sweden in 2003–2009. All subjects are unrelated and of western European origin, with both parents born in Sweden. The diagnosis of birch and/or grass pollen induced AR was based on a positive history of AR for at least two years and a positive skin prick test (SPT) or Phadiatop test with at least class two to birch and/or timothy grass pollen. A total of 59% of the patients showed a positive SPT for both allergens. All patients were classified as having severe symptoms i.e., nasal itching, sneezing, rhinorrhea and nasal congestion during pollen season and they had all been treated with antihistamines and nasal steroids during pollen seasons previous years. Control individuals had no history of AR or any other atopic disease and had a negative SPT or Phadiatop test. Genomic DNA was extracted from blood collected in EDTA using QIAamp DNA Blood Maxi or Mini kits (Qiagen, Hilden, Germany) and DNA concentrations determined by fluorometry using PicoGreen (Molecular Probes, Invitrogen, Eugene, OR, USA). The Swedish study population has previously been analyzed in several AR studies [4,15-17]. The Singapore Chinese population consists of 448 AR patients (250 female, 198 male) and 462 control individuals (337 female and 125 male) and was collected in Singapore between 2008 and 2010. The study population is of Chinese origin, residence of Singapore and all subjects are unrelated to one another. The diagnosis of dust mite induced AR was based on interviews of medical history using a standardized questionnaire and SPTs performed using a panel of common allergens in Singapore including the house dust mite Dermatophagoides pteronyssinus and Blomia tropicalis. A total of 89% of the patients showed a positive SPT for both allergens. AR is thus diagnosed based on the presence of atopic status and typical AR symptoms as defined by the ARIA 2008 guidelines i.e., two or more AR symptoms (nasal congestion, rhinorrhea, nasal itching, sneezing) persisting for four or more days a week during the past year. In this study, none of the patients suffered from severe asthma and less than 10% had moderate asthma with continuous medication. Control individuals had no history of AR or any other atopic disease and had a negative SPT. More detailed phenotypic characteristics of the Singapore Chinese population have been described previously [5]. Genomic DNA was extracted from buccal cells obtained from a mouthwash of 0.9% saline solution following a standardized protocol [18]. Samples were quantified in triplicate on the Nanodrop (Thermo Fisher Scientific Inc, Wilmington, DE, USA). In both populations, SPT were performed with saline buffer as negative and histamine chloride as positive controls. A wheal reaction diameter of more than three mm was considered a positive SPT response. SPT was only performed if the AR cases had not taken any anti-allergic drugs for at least three days prior to the test. Atopy is defined as a positive SPT reaction to either one of allergens. The study was approved by the Ethics Committee of the Medical Faculty, Lund University and the Institutional Review Board of National University of Singapore and written informed consent was obtained from all subjects. This study is also in compliance with the Helsinki declaration.

Genotyping

A total of 21 genes (IL4, IL13, CD14, MS4A2 (FCERB1), IL4R (IL4RA), ADAM33, GSTM1, IL10, CTLA4, SPINK5, LTC4S, NPSR1 (GPR154), NOD1 (CARD4), SCGB1A1 (CC16), GSTP1, STAT6, NOS1, CCL5, TBXA2R, ADRB2 and TGFB1) were selected from a compilation of 25 genes reported to be associated with asthma phenotypes in six or more unrelated independent studies [11]. SNPs of the 21 genes were analyzed for association with AR whereas no SNPs were analyzed for HLA-DRB1, HLA-DQB1, TNF, and LTA as they are located at the HLA locus. Since this study investigates asthma genes for their eventual contribution also to the AR phenotype, we use the gene as the replication unit and not the individual SNPs. For genotyping in the Swedish study population, HapMap (release 24) data were used to identify haplotype-tagging SNPs (r2 cut off =0.8, and minor allele frequency cut off =0.2) for each of the 21 genes. Non-synonymous SNPs reported in dbSNP or HapMap with minor allele frequencies >5% was added to this selection. Genotypes were determined using the Sequenom MassARRAY MALDI-TOF system. Assay design was made using the MassARRAY Assay Design ver. 2.0 software (Sequenom Inc, San Diego, CA, USA) and primers were obtained from Metabion GmbH (Martinsried, Germany). A total of 192 SNPs with a total genotyping rate of 98.4% were analyzed for association with AR in 246 patients and 431 controls. Whole genome genotyping in the Singapore Chinese population was performed using the Illumina HumanHap 550 k BeadChip version 3 (Illumina, San Diego, CA, USA) at the Genome Institute of Singapore as described earlier [5]. Of the 21 genes initially selected, three genes (LTC4S, NOD1 and GSTM1) had no SNPs in the Illumina Human Hap 550k panel while CCL5 had one SNP but was filtered out after quality control for SNPs. A total of 413 SNPs from 17 unique genes with a total genotyping rate of 98.4% were analyzed for association with AR in 448 patients and 462 controls. Additional samples (921 AR patients, 390 controls) from the Singapore Chinese cohort were genotyped for rs324981, using a Taqman-assay. Reactions were carried out according to the manufacturer’s protocol using an ABI PRISM 7900HT and the genotypes determined using SDS 2.4 software (Applied Biosystems, Foster City, CA, USA).

Statistical analysis

Statistical analyses were made using R statistical software [19] and PLINK v1.07 [20]. Genotype frequencies were calculated and tested for Hardy-Weinberg equilibrium in both cases and controls. Allele and genotype frequencies were then investigated for association with AR using a χ2-homogeneity test. Odds ratios and 95% confidence intervals were estimated by using the most common allele as the referent and are reported for each minor allele. Associations between SPT-response and genotype were analyzed using Kruskal-Wallis rank sum test. False discovery rate was quantified using the Q-value introduced by Storey [21] and calculated using the software QVALUE (ver.1.0).

Results

Association with AR phenotype in the Swedish population

A total of 192 SNPs from 21 genes were genotyped and analyzed for association with AR in 246 patients and 431 controls. For each SNP two tests of association were made, one of allele frequencies and one of genotype frequencies. Table 1 shows the results of the association analysis for SNPs with uncorrected P-values <0.05 and the corresponding Q-values and ORs (for complete results see Additional file 1: Table S1). In the tests of allele frequencies there were two P-values <0.01 and 11 P-values <0.05. In the tests of genotype frequencies there were three P-values <0.01 and eight P-values <0.05. None of the indicated SNPs had Q-values <0.1. In the absence of any association, the expected numbers of P-values <0.01 and <0.05 are 1.9 and 9.6, respectively, in each of the test categories. Thus, the results fit very well the expected pattern of P-values in the absence of any effects.
Table 1

Minor allele frequencies (MAF) and P-values for Hardy-Weinberg (HW) and association tests for SNPs with P<0.05 in the Swedish population

GeneSNP IDChromosome positionStudy MAFHW testAssociation test
OR95% CI
AlleleGenotypeLowerUpper
IL10
rs3021094
1
206944952
0.092
0.16
0.020
(0.72)
0.078
(0.92)
1.6
1.1
2.2
NOD1
rs4363092
7
30503938
0.18
0.36
0.050
(0.72)
0.045
(0.92)
1.3
1.0
1.8
NOD1
rs4720003
7
30508992
0.18
0.37
0.041
(0.72)
0.033
(0.92)
1.3
1.0
1.8
NPSR1
rs2022142
7
34705950
0.10
1.0
0.035
(0.72)
0.056
(0.92)
1.5
1.0
2.1
NPSR1
rs1379925
7
34715128
0.091
1.0
0.021
(0.72)
0.031
(0.92)
1.6
1.1
2.3
NPSR1
rs1379923
7
34717238
0.25
0.41
0.045
(0.72)
0.11
(0.92)
0.8
0.6
1.0
NPSR1
rs17788770
7
34793991
0.10
0.68
0.083
(0.72)
0.035
(0.92)
0.7
0.5
1.0
NPSR1
rs17789834
7
34871328
0.19
0.32
0.011
(0.70)
0.039
(0.92)
1.4
1.1
1.9
SCGB1A1
rs11231085
11
62190448
0.36
0.74
0.037
(0.72)
0.0049
(0.58)
1.3
1.0
1.6
CCL5
rs1065341
17
34198593
0.040
0.41
0.027
(0.72)
0.085
(0.92)
1.8
1.1
3.2
CCL5
rs3817655
17
34199641
0.17
0.12
0.0028
(0.29)
0.0088
(0.58)
1.6
1.2
2.1
CCL5
rs2107538
17
34207780
0.17
0.27
0.0021
(0.29)
0.0069
(0.58)
1.6
1.2
2.1
TBXA2Rrs37869891936040040.930.250.038(0.72)0.086(0.92)0.60.41.0

†Association with AR estimated using a χ2-homogeneity test with Q-values in parenthesis calculated according to Storey (2002).

Odds ratio (OR) and 95% confidence interval were estimated by using the most common allele as the referent and are reported for each minor allele.

Minor allele frequencies (MAF) and P-values for Hardy-Weinberg (HW) and association tests for SNPs with P<0.05 in the Swedish population †Association with AR estimated using a χ2-homogeneity test with Q-values in parenthesis calculated according to Storey (2002). Odds ratio (OR) and 95% confidence interval were estimated by using the most common allele as the referent and are reported for each minor allele.

Association with SPT response in the Swedish population

A Kruskal-Wallis rank sum test was used to investigate the relationship between genotype and degree of sensitization to birch and timothy grass in AR-patients. A total of 24 SNPs had P-values <0.05 in the tests of SPTs for birch or timothy grass (Table 2 and Additional file 1: Table S1). In the tests of birch there were three P-values <0.001, four at P<0.01 and 10 at P<0.05 and in the test of timothy grass there were one P-value <0.01 and 16 at P<0.05. The Q-values of the three SNPs with P<0.001 for birch (rs1138272 in GSTP1, rs20541 and rs848 in IL13) were approximately 0.04 and all other Q-values were >0.1. The lowest P-value (rs1138272) is below the level for a Bonferroni corrected P-value of 0.05, i.e. 0.00022 vs. 0.00026. Although the overall distribution of P-values is close to the expectation under the assumption of absence of any association, the three P-values <0.001 can be considered an indication of an effect that warrants further investigation.
Table 2

Association of SNPs with P<0.05 for sensitization to allergens in the Swedish population

GeneSNP IDChromosome positionKruskal-Wallis test
BirchTimothy
IL10
rs3024498
1
206941529
0.27
(0.95)
0.0094
(0.31)
IL10
rs3024492
1
206944112
0.17
(0.87)
0.025
(0.36)
IL13
rs20541
5
131995964
0.00040
(0.038)
0.58
(0.77)
IL13
rs848
5
131996500
0.00067
(0.043)
0.56
(0.77)
IL4
rs2243248
5
132008644
0.0044
(0.21)
0.52
(0.76)
IL4
rs2070874
5
132009710
0.051
(0.87)
0.016
(0.31)
IL4
rs2227284
5
132012725
0.015
(0.57)
0.18
(0.59)
IL4
rs2243266
5
132013789
0.046
(0.87)
0.014
(0.31)
IL4
rs2243288
5
132017944
0.046
(0.87)
0.013
(0.31)
SPINK5
rs4357026
5
147457939
0.77
(0.99)
0.048
(0.45)
SPINK5
rs9325073
5
147498652
0.90
(0.99)
0.020
(0.31)
SPINK5
rs1422993
5
147503820
0.96
(0.99)
0.015
(0.31)
SPINK5
rs4263489
5
147516195
0.049
(0.87)
0.61
(0.77)
LTC4S
rs730012
5
179220638
0.042
(0.87)
0.57
(0.77)
NPSR1
rs323917
7
34741643
0.048
(0.87)
0.35
(0.63)
NPSR1
rs12534369
7
34804709
0.64
(0.96)
0.033
(0.43)
NPSR1
rs17170017
7
34874209
0.54
(0.95)
0.011
(0.31)
N.D.
rs10897270
11
62183007
0.90
(0.99)
0.012
(0.31)
GSTP1
rs1138272
11
67353579
0.00022
(0.038)
0.20
(0.61)
NOS1
rs6490121
12
117708195
0.33
(0.95)
0.036
(0.44)
NOS1
rs12578547
12
117763347
0.091
(0.87)
0.018
(0.31)
NOS1
rs3782218
12
117771511
0.96
(0.99)
0.046
(0.45)
NOS1
rs17509231
12
117794323
0.43
(0.95)
0.011
(0.31)
IL4Rrs102948916273762170.46(0.95)0.039(0.44)

Association between genotype and sensitization to allergens was analyzed using a Kruskal-Wallis rank sum test. False discovery rate was quantified using the q-value introduced by Storey(2002) and are given in parenthesis.

Association of SNPs with P<0.05 for sensitization to allergens in the Swedish population Association between genotype and sensitization to allergens was analyzed using a Kruskal-Wallis rank sum test. False discovery rate was quantified using the q-value introduced by Storey(2002) and are given in parenthesis.

Association with AR phenotype in the Chinese population

Of the 21 genes initially selected, a total of 413 SNPs from 17 genes were extracted from the Illumina Human Hap 550 k panel and tested for association with AR in the Singapore Chinese population. Just as in the Swedish population two association tests were made, one at the allele and one at the genotype level. Table 3 shows the results of the association analysis for SNPs with uncorrected P-values <0.05 and the corresponding Q-values and ORs (for complete results see Additional file 2: Table S2). A total of 50 SNPs had P-values <0.05. In the association test of alleles there were nine P-values <0.001, 18 at P< 0.01 and a total of 48 at P<0.05. All nine SNPs with P-values <0.001 had Q-values <0.05 and corresponds to rs10270663, rs324389, rs324957, rs10278663, rs324396, rs10267134, rs324987 in NPSR1/AAA1, and rs231804 and rs231735 in CTLA4. In the tests of association at the genotype level, the four lowest P-values were <0.001with Q-values <0.05 and coincided with the lowest P-values in the allele test. In addition, another nine P-values were <0.01 and five of them had Q-values <0.1. Of these five, four also coincide with the nine SNPs with P<0.001 in the allele test. In total, there were 30 P-values <0.05. In the absence of any association, the expected number of P-values <0.001, <0.01 and <0.05 are 0.4, 4.1 and 20.7, respectively, in each of the test categories. Thus, the observed numbers of significant P-values exceeds the expectation in the absence of any association for both the allele and the genotype tests. In the tests of allele effects, three P-values were lower than 0.00012 which is the Bonferroni limit at P=0.05 within each category. The lowest P-value, 0.000068, is larger than 0.00003 equal to the global Bonferroni limit for all tests taken together, but of the same order of magnitude. Thus, these results give a strong indication of a genetic effect of NPSR1/AAA1 and CTLA4 on the occurrence of AR, i.e. these genes can be considered strong candidates for future analyses.
Table 3

Minor allele frequencies (MAF) and P-values for Hardy-Weinberg (HW) and association tests for SNPs with P<0.05 in the Chinese population

GeneSNP IDChromosome positionStudy MAFHW testAssociation test
OR95% CI
AlleleGenotypeLowerUpper
CTLA4
rs231735
2
204402121
0.23
1.0
0.00090
(0.037)
0.0038
(0.12)
1.44
1.16
1.79
CTLA4
rs231804
2
204416891
0.22
0.93
0.00060
(0.028)
0.0025
(0.090)
1.46
1.18
1.82
CTLA4
rs1024161
2
204429997
0.34
0.57
0.0088
(0.21)
0.020
(0.34)
1.29
1.07
1.56
CTLA4
rs926169
2
204430997
0.34
0.89
0.0059
(0.20)
0.016
(0.29)
1.31
1.08
1.58
CTLA4
rs733618
2
204439189
0.40
1.0
0.012
(0.22)
0.030
(0.42)
0.79
0.66
0.95
CTLA4
rs231726
2
204449111
0.40
0.74
0.016
(0.22)
0.041
(0.50)
1.25
1.04
1.51
CTLA4
rs6748358
2
204465150
0.28
0.39
0.0077
(0.21)
0.0067
(0.18)
1.31
1.08
1.61
CTLA4
rs10197319
2
204471289
0.22
0.86
0.013
(0.22)
0.0058
(0.17)
1.31
1.06
1.63
CTLA4
rs3096851
2
204472127
0.40
0.90
0.015
(0.22)
0.028
(0.41)
1.26
1.05
1.51
CTLA4
rs3116504
2
204477299
0.40
0.90
0.015
(0.22)
0.028
(0.41)
1.26
1.05
1.51
SPINK5
rs7707803
5
147368427
0.33
0.23
0.021
(0.27)
0.077
(0.57)
1.25
1.03
1.52
SPINK5
rs7725292
5
147368581
0.33
0.28
0.017
(0.22)
0.061
(0.51)
1.27
1.04
1.54
SPINK5
rs10477360
5
147384474
0.50
0.90
0.037
(0.34)
0.066
(0.52)
0.82
0.69
0.99
SPINK5
rs12332673
5
147387572
0.12
0.17
0.045
(0.36)
NA
(NA)
0.75
0.56
0.99
SPINK5
rs11948836
5
147393693
0.12
0.17
0.039
(0.34)
NA
(NA)
0.74
0.56
0.99
SPINK5
rs17774892
5
147395161
0.12
0.88
0.035
(0.34)
NA
(NA)
0.74
0.55
0.98
SPINK5
rs10463396
5
147395535
0.20
1.0
0.016
(0.22)
0.053
(0.50)
0.76
0.60
0.95
SPINK5
rs17107650
5
147396591
0.12
0.17
0.039
(0.34)
NA
(NA)
0.74
0.56
0.99
SPINK5
rs1422982
5
147400217
0.20
1.00
0.016
(0.22)
0.053
(0.50)
0.76
0.60
0.95
SPINK5
rs17107673
5
147401681
0.12
0.29
0.041
(0.34)
NA
(NA)
0.74
0.56
0.99
SPINK5
rs4472254
5
147433830
0.20
0.69
0.016
(0.22)
0.044
(0.50)
0.76
0.60
0.95
SPINK5
rs7724165
5
147445445
0.50
0.80
0.027
(0.30)
0.054
(0.50)
1.23
1.02
1.47
SPINK5
rs4519913
5
147452004
0.50
0.85
0.024
(0.27)
0.057
(0.50)
0.81
0.68
0.97
ADRB2
rs11742519
5
148218501
0.45
0.90
0.039
(0.34)
0.056
(0.50)
1.21
1.01
1.45
NPSR1
rs411323
7
34668233
0.16
0.81
0.037
(0.34)
0.095
(0.62)
1.31
1.02
1.69
NPSR1/AAA1
rs10081183
7
34706738
0.45
0.66
0.0066
(0.21)
0.023
(0.36)
0.78
0.65
0.93
NPSR1/AAA1
rs1345267
7
34714584
0.46
0.31
0.012
(0.22)
0.036
(0.48)
0.79
0.66
0.95
NPSR1/AAA1
rs1419791
7
34722086
0.48
0.85
0.0096
(0.21)
0.010
(0.21)
1.27
1.06
1.52
NPSR1/AAA1
rs1419791
7
34722086
0.48
0.85
0.0096
(0.21)
0.010
(0.21)
1.27
1.06
1.52
NPSR1/AAA1
rs324374
7
34723121
0.48
0.90
0.0095
(0.21)
0.010
(0.21)
1.27
1.06
1.52
NPSR1/AAA1
rs324389
7
34744239
0.46
0.66
0.00010
(0.014)
0.00055
(0.044)
0.70
0.58
0.84
NPSR1/AAA1
rs10270663
7
34752923
0.46
0.52
0.000068
(0.014)
0.00038
(0.044)
0.69
0.58
0.83
NPSR1/AAA1
rs324396
7
34756648
0.42
1.0
0.00035
(0.021)
0.0012
(0.065)
1.40
1.16
1.68
NPSR1/AAA1
rs324957
7
34767897
0.43
0.61
0.00011
(0.014)
0.00052
(0.044)
1.44
1.20
1.73
NPSR1/AAA1
rs10267134
7
34769628
0.34
0.89
0.00039
(0.021)
0.0014
(0.065)
0.71
0.58
0.86
NPSR1/AAA1
rs10278663
7
34774996
0.34
0.83
0.00032
(0.021)
0.0012
(0.065)
0.70
0.58
0.85
NPSR1
rs324987
7
34787953
0.44
0.34
0.00021
(0.019)
0.00049
(0.044)
1.41
1.18
1.70
NPSR1
rs17199888
7
34830864
0.33
0.89
0.0022
(0.083)
0.0075
(0.18)
0.74
0.61
0.90
NPSR1
rs1419868
7
34834082
0.25
0.018
0.013
(0.22)
0.054
(0.50)
1.31
1.06
1.61
GSTP1
rs614080
11
67103863
0.28
0.44
0.40
(0.80)
0.050
(0.50)
1.09
0.89
1.33
NOS1
rs884847
12
116207996
0.15
0.90
0.26
(0.75)
0.043
(0.50)
1.01
0.90
1.50
NOS1
rs532967
12
116216722
0.20
0.55
0.032
(0.34)
0.0024
(0.090)
1.03
1.02
1.62
NOS1
rs545654
12
116261432
0.32
0.47
0.019
(0.24)
0.043
(0.50)
1.19
0.65
0.96
NOS1
rs693534
12
116269101
0.28
0.64
0.0094
(0.21)
0.014
(0.29)
0.84
0.62
0.94
NOS1
rs3782221
12
116280264
0.49
0.31
0.024
(0.27)
0.047
(0.50)
1.08
0.67
0.97
NOS1
rs11068466
12
116320260
0.17
0.73
0.023
(0.27)
0.016
(0.29)
0.91
0.59
0.96
NOS1
rs10774914
12
116331323
0.12
0.56
0.042
(0.34)
0.10
(0.62)
1.13
1.01
1.78
IL4R
rs3024535
16
27259622
0.16
0.023
0.034
(0.34)
NA
(NA)
1.31
1.02
1.68
IL4R
rs3024585
16
27267345
0.38
0.12
0.034
(0.34)
0.088
(0.62)
0.82
0.68
0.99
IL4Rrs207457016272826580.070.630.040(0.34)NA(NA)1.451.022.07

†Association with AR estimated using a χ2-homogeneity test with Q-values in parenthesis calculated according to Storey (2002).

Odds ratio (OR) and 95% confidence interval were estimated by using the most common allele as the referent and are reported for each minor allele.

Minor allele frequencies (MAF) and P-values for Hardy-Weinberg (HW) and association tests for SNPs with P<0.05 in the Chinese population †Association with AR estimated using a χ2-homogeneity test with Q-values in parenthesis calculated according to Storey (2002). Odds ratio (OR) and 95% confidence interval were estimated by using the most common allele as the referent and are reported for each minor allele. In addition, we investigated the functional NPSR1 coding variant rs324981 (Ile107Asn), which is in complete linkage disequilibrium with rs324987 (P-value for association =0.00021, OR=1.41, see Table 3). A TaqMan assay was used to determine the rs324981 genotypes of additional individuals of the Singapore Chinese cohort (921 AR patients, 390 controls). The P-value of association was 0.0070 with an odds ratio (OR) of 1.14 for the heterozygous genotype and an increased OR of 1.65 for the homozygous genotype in comparison with the reference genotype. Thus, both analyses support the involvement of NPSR1 in AR. Since genetic variation of all genes tested for association with AR in the present study has previously been associated with asthma and since patients with AR have an increased incidence of asthma, we investigated asthma as a confounding factor for our results. Since the strongest associations are detected in the Chinese population, we excluded all Chinese patients with any asthmatic symptoms and repeated the association analysis for this population (Additional file 3: Table S3). Comparing the significant association results before and after elimination of AR patients with asthma shows that: 1) The elimination of 144 patients with asthma out of 448 (32%) result in a general increase in P-values corresponding to the loss of power due to a smaller sample size, 2) the nine SNPs with P-values <0.001 detected in the initial analysis of all 448 AR patients, all showed P-values ≤0.01 after elimination of the 144 patients, 3) these SNPs also showed very small changes in their ORs (<0.08), 4) most ORs were highly similar before and after elimination of the 144 patients, the exception being five SNPs in the NOS1 gene that may indicate confounding due to asthma.

Association with SPT response in the Chinese population

A Kruskal-Wallis rank sum test was used to investigate the relationship between genotype and degree of sensitization to D. pteronyssinus and B. tropicalis in AR-patients. All tests of the SPT with an uncorrected P-value <0.05 are shown in Table 4 (for complete results see Additional file 2: Table S2). A total of 44 SNPs had P-values <0.05 in the tests of D. pteronyssinus and B. tropicalis. In the tests of B. tropicalis there were six P-values <0.01 and a total of 24 P-values <0.05. In the tests of D. pteronyssinus one P-value was <0.001, six were <0.01 and a total of 22 were <0.05. None of the indicated SNPs had corresponding Q-values <0.1. Thus, the tests of the SPT response conformed well to the expectations under independence and give therefore no indication of any association with sensitization of the tested allergens.
Table 4

Association of SNPs with P<0.05 for sensitization to allergens in the Chinese population

GeneSNP IDChromosome positionKruskal-Wallis test
B.tropicalisD. pteronyssinus
SPINK5
rs10477360
5
147384474
0.027
(0.65)
0.69
(1.0)
ADRB2
rs2163752
5
148125331
0.027
(0.65)
0.054
(0.92)
ADRB2
rs30306
5
148132557
0.028
(0.65)
0.074
(0.97)
ADRB2
rs30325
5
148143517
0.27
(0.82)
0.010
(0.52)
ADRB2
rs30328
5
148146640
0.28
(0.82)
0.025
(0.75)
ADRB2
rs30330
5
148148525
0.32
(0.82)
0.027
(0.75)
ADRB2
rs9285673
5
148153121
0.049
(0.78)
0.90
(1.0)
ADRB2
rs10075995
5
148273622
0.53
(0.82)
0.014
(0.52)
NPSR1/AAA1
rs2058163
7
34301616
0.049
(0.78)
0.025
(0.75)
NPSR1/AAA1
rs1419842
7
34321625
0.41
(0.82)
0.031
(0.75)
NPSR1/AAA1
rs2392268
7
34380952
0.44
(0.82)
0.031
(0.75)
NPSR1/AAA1
rs6947789
7
34417405
0.018
(0.65)
0.83
(1.0)
NPSR1/AAA1
rs736295
7
34417742
0.054
(0.79)
0.039
(0.75)
NPSR1
rs2530545
7
34663665
0.94
(0.90)
0.040
(0.75)
NPSR1
rs11761197
7
34666914
0.78
(0.90)
0.013
(0.52)
NPSR1
rs1379928
7
34667814
0.51
(0.82)
0.0098
(0.52)
NPSR1
rs2609224
7
34672931
0.62
(0.85)
0.011
(0.52)
NPSR1
rs2609220
7
34676579
0.68
(0.86)
0.0067
(0.52)
NPSR1
rs2531841
7
34686074
0.81
(0.90)
0.012
(0.52)
NPSR1
rs1419837
7
34692064
0.88
(0.90)
0.018
(0.62)
NPSR1
rs1419779
7
34779833
0.21
(0.82)
0.0011
(0.15)
NPSR1
rs324978
7
34780857
0.20
(0.82)
0.00098
(0.15)
NPSR1
rs1859409
7
34906409
0.049
(0.78)
0.83
(1.0)
NPSR1
rs4723388
7
34909345
0.0056
(0.51)
0.52
(0.98)
NPSR1
rs1186717
7
34937434
0.33
(0.82)
0.036
(0.75)
NPSR1
rs1637673
7
34964375
0.15
(0.82)
0.0081
(0.52)
NPSR1
rs4236340
7
34976719
0.0061
(0.51)
0.46
(0.98)
NPSR1
rs328902
7
34987368
0.41
(0.82)
0.038
(0.75)
NPSR1
rs328906
7
34990440
0.0080
(0.51)
0.58
(0.98)
NPSR1
rs2023328
7
34998155
0.0053
(0.51)
0.60
(0.98)
NPSR1
rs329240
7
35024965
0.41
(0.82)
0.038
(0.75)
MS4A2
rs540170
11
59636614
0.049
(0.78)
0.98
(1.0)
MS4A2
rs581133
11
59638882
0.043
(0.78)
0.99
(1.0)
NOS1
rs1093325
12
116179703
0.031
(0.7)
0.23
(0.98)
NOS1
rs1004356
12
116261755
0.026
(0.65)
0.43
(0.98)
IL4R
rs3024585
16
27267345
0.0036
(0.51)
0.98
(1.0)
IL4R
rs1805011
16
27281373
0.011
(0.51)
0.076
(0.97)
IL4R
rs1805012
16
27281465
0.011
(0.51)
0.076
(0.97)
IL4R
rs1805015
16
27281681
0.022
(0.65)
0.11
(0.97)
IL4R
rs3024685
16
27284411
0.045
(0.78)
0.21
(0.98)
IL4R
rs4787956
16
27285750
0.0087
(0.51)
0.17
(0.97)
IL4R
rs4787426
16
27292232
0.026
(0.65)
0.37
(0.98)
ADAM33
rs512625
20
3596378
0.017
(0.65)
0.22
(0.98)
ADAM33rs28532102036062110.046(0.78)0.0010(0.15)

Association between genotype and sensitization to allergens was analyzed using a Kruskal-Wallis rank sum test. False discovery rate was quantified using the q-value introduced by Storey(2002) and are given in parenthesis.

Association of SNPs with P<0.05 for sensitization to allergens in the Chinese population Association between genotype and sensitization to allergens was analyzed using a Kruskal-Wallis rank sum test. False discovery rate was quantified using the q-value introduced by Storey(2002) and are given in parenthesis.

Discussion

In this study, we investigated the SNP associations of well-replicated asthma candidate genes with AR in two independent populations, one Swedish and one Singapore Chinese population. Since there are inherent differences in the genetic architecture between the two populations and this study investigates asthma genes for their eventual contribution also to the AR phenotype, the gene was used as the level of replication and not the individual SNP [22]. A limited number of potential associations were observed and the overall pattern of P-values corresponds in general well to the expectations in the absence of an effect. However, in the tests of allele effects in the Chinese population, the number of significant P-values exceeds the expectations. The strongest signals were found for SNPs in CTLA4 and NPSR1. In each of these genes, more than one SNP showed P-values <0.05 with corresponding Q-values <0.05. In the NPSR1 gene some P-values were lower than the Bonferroni correction level indicating the existence of a true association. When comparing the results from the two populations, i.e. Table 1 vs Table 3 and Table 2 vs Table 4, it is with few exceptions different genes that show significant SNPs. This is what is expected if the significances mainly are due to chance effects generated by the multiple testing. The conclusion that there are few genes in common between AR and asthma is further strengthened by this observation. On the other hand, there is one exception to this, the NPSR1 gene that recurs in all four tables. This observation in turn further point to this gene as the strongest candidate for being a link between AR and asthma, even if one keep in mind the fact that the NPSR1 gene is represented by the largest number of SNPs in both populations. To further investigate this hypothesis, one SNP in NPSR1 (rs324981) was evaluated in an independent sample of 921 AR patients and 390 controls from the Singapore Chinese population. The results (OR=1.65, P=0.007) further strengthen this hypothesis. Previous studies have reported significant associations for a large region of 47 kb in the NPSR1 gene with asthma even after Bonferroni correction for multiple comparisons (P<0.001). Vergara et al. [23], investigated SNPs in the NPSR1 (GPR154) gene and found associations with asthma and total IgE. Furthermore, this gene has been replicated in studies of Caucasian [24-28] and Chinese populations [29], but was not replicated in a Mexican cohort of childhood asthmatics [30]. Thus, the association between variation in NPSR1 and asthma appear to be strongly supported. Since the present study strongly indicates an association with genetic variation in the NPSR1 gene also in AR, there is an obvious risk of asthma being a cxonfounding factor for our results. This was investigated by comparing the association results before and after elimination of patients with any symptoms of asthma. The results convincingly showed that asthma is no confounding factor for the SNPs in NPSR1 and CTLA4 in the Chinese population. The present result indicates that NPSR1 could be a genetic link between AR and asthma and associations of NPSR1 polymorphisms with AR have not been reported prior to this.

Conclusion

In summary, we have identified NPSR1 and CTLA4 as potential susceptibility genes for AR. However, these genes need to be replicated in additional populations and further characterized to elucidate their role in AR predisposition and pathogenesis. The majority of the highly replicated asthma genes were not associated with AR in our populations, which suggest that asthma and AR could be less similar at the genetic level than previously anticipated.

Competing interests

The authors state that they have no financial or non-financial competing interests.

Authors’ contributions

AKA, CFT, CH and LOC designed the study. AKA, TS and DN performed the data analysis and AKA, DN, CH and TS wrote the manuscript. All authors critically revised the manuscript and approved the final form of the manuscript. All authors read and approved the final manuscript.

Pre-publication history

The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2350/14/51/prepub

Additional file 1: Table S1

Complete association results for the AR phenotype and allergen sensitization in the Swedish population. Click here for file

Additional file 2: Table S2

Complete association results for the AR phenotype and allergen sensitization in the Chinese population. Click here for file

Additional file 3: Table S3

Comparison of association test results before (448 patients) and after. Click here for file
  27 in total

1.  The future of association studies: gene-based analysis and replication.

Authors:  Benjamin M Neale; Pak C Sham
Journal:  Am J Hum Genet       Date:  2004-07-22       Impact factor: 11.025

Review 2.  Asthma genetics 2006: the long and winding road to gene discovery.

Authors:  C Ober; S Hoffjan
Journal:  Genes Immun       Date:  2006-03       Impact factor: 2.676

3.  Haplotypes of G protein-coupled receptor 154 are associated with childhood allergy and asthma.

Authors:  Erik Melén; Sara Bruce; Gert Doekes; Michael Kabesch; Tarja Laitinen; Roger Lauener; Cecilia M Lindgren; Josef Riedler; Annika Scheynius; Marianne van Hage-Hamsten; Juha Kere; Göran Pershagen; Magnus Wickman; Fredrik Nyberg
Journal:  Am J Respir Crit Care Med       Date:  2005-02-11       Impact factor: 21.405

4.  Chromosome 7p linkage and GPR154 gene association in Italian families with allergic asthma.

Authors:  G Malerba; C M Lindgren; L Xumerle; P Kiviluoma; E Trabetti; T Laitinen; R Galavotti; L Pescollderungg; A L Boner; J Kere; P F Pignatti
Journal:  Clin Exp Allergy       Date:  2007-01       Impact factor: 5.018

5.  G-Protein-coupled receptor polymorphisms are associated with asthma in a large German population.

Authors:  Michael S D Kormann; David Carr; Norman Klopp; Thomas Illig; Wolfgang Leupold; Christian Fritzsch; Stephan K Weiland; Erika von Mutius; Michael Kabesch
Journal:  Am J Respir Crit Care Med       Date:  2005-03-11       Impact factor: 21.405

6.  Characterization of a common susceptibility locus for asthma-related traits.

Authors:  Tarja Laitinen; Anne Polvi; Pia Rydman; Johanna Vendelin; Ville Pulkkinen; Paula Salmikangas; Siru Mäkelä; Marko Rehn; Asta Pirskanen; Anna Rautanen; Marco Zucchelli; Harriet Gullstén; Marina Leino; Harri Alenius; Tuula Petäys; Tari Haahtela; Annika Laitinen; Catherine Laprise; Thomas J Hudson; Lauri A Laitinen; Juha Kere
Journal:  Science       Date:  2004-04-09       Impact factor: 47.728

7.  Hay fever--a Finnish nationwide study of adolescent twins and their parents.

Authors:  M Räsänen; T Laitinen; J Kaprio; M Koskenvuo; L A Laitinen
Journal:  Allergy       Date:  1998-09       Impact factor: 13.146

8.  The link between allergic rhinitis and allergic asthma: a prospective population-based study. The Copenhagen Allergy Study.

Authors:  A Linneberg; N Henrik Nielsen; L Frølund; F Madsen; A Dirksen; T Jørgensen
Journal:  Allergy       Date:  2002-11       Impact factor: 13.146

9.  G protein-coupled receptor 154 gene polymorphism is associated with airway hyperresponsiveness to methacholine in a Chinese population.

Authors:  Yan Feng; Xiumei Hong; Lin Wang; Shanqun Jiang; Changzhong Chen; Binyan Wang; Jianhua Yang; Zhian Fang; Tonghua Zang; Xiping Xu; Xin Xu
Journal:  J Allergy Clin Immunol       Date:  2006-02-15       Impact factor: 10.793

10.  Poor reproducibility of allergic rhinitis SNP associations.

Authors:  Daniel Nilsson; Anand Kumar Andiappan; Christer Halldén; Chew Fook Tim; Torbjörn Säll; De Yun Wang; Lars-Olaf Cardell
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

View more
  7 in total

1.  International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis.

Authors:  Sarah K Wise; Sandra Y Lin; Elina Toskala; Richard R Orlandi; Cezmi A Akdis; Jeremiah A Alt; Antoine Azar; Fuad M Baroody; Claus Bachert; G Walter Canonica; Thomas Chacko; Cemal Cingi; Giorgio Ciprandi; Jacquelynne Corey; Linda S Cox; Peter Socrates Creticos; Adnan Custovic; Cecelia Damask; Adam DeConde; John M DelGaudio; Charles S Ebert; Jean Anderson Eloy; Carrie E Flanagan; Wytske J Fokkens; Christine Franzese; Jan Gosepath; Ashleigh Halderman; Robert G Hamilton; Hans Jürgen Hoffman; Jens M Hohlfeld; Steven M Houser; Peter H Hwang; Cristoforo Incorvaia; Deborah Jarvis; Ayesha N Khalid; Maritta Kilpeläinen; Todd T Kingdom; Helene Krouse; Desiree Larenas-Linnemann; Adrienne M Laury; Stella E Lee; Joshua M Levy; Amber U Luong; Bradley F Marple; Edward D McCoul; K Christopher McMains; Erik Melén; James W Mims; Gianna Moscato; Joaquim Mullol; Harold S Nelson; Monica Patadia; Ruby Pawankar; Oliver Pfaar; Michael P Platt; William Reisacher; Carmen Rondón; Luke Rudmik; Matthew Ryan; Joaquin Sastre; Rodney J Schlosser; Russell A Settipane; Hemant P Sharma; Aziz Sheikh; Timothy L Smith; Pongsakorn Tantilipikorn; Jody R Tversky; Maria C Veling; De Yun Wang; Marit Westman; Magnus Wickman; Mark Zacharek
Journal:  Int Forum Allergy Rhinol       Date:  2018-02       Impact factor: 3.858

2.  Single nucleotide polymorphisms of IL-13 and CD14 genes in allergic rhinitis: a meta-analysis.

Authors:  Min-Li Chen; Hua Zhao; Qiu-Pin Huang; Zheng-Fu Xie
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-04-23       Impact factor: 2.503

3.  Genetic Variations in Nucleotide Excision Repair Pathway Genes and Risk of Allergic Rhinitis.

Authors:  Wenlong Liu; Qingxiang Zeng; Yinhui Zeng; Yiquan Tang; Renzhong Luo
Journal:  Mediators Inflamm       Date:  2022-06-03       Impact factor: 4.529

Review 4.  Genetic risk factors for the development of allergic disease identified by genome-wide association.

Authors:  M A Portelli; E Hodge; I Sayers
Journal:  Clin Exp Allergy       Date:  2015-01       Impact factor: 5.018

5.  Inflammation and airway remodeling of the lung in guinea pigs with allergic rhinitis.

Authors:  Zu-Yao Chen; Shou-Hong Zhou; Qiao-Feng Zhou; Hong-Bo Tang
Journal:  Exp Ther Med       Date:  2017-08-16       Impact factor: 2.447

6.  Association of FcεRIβ polymorphisms with risk of asthma and allergic rhinitis: evidence based on 29 case-control studies.

Authors:  Huanhuan Guo; Tao Peng; Ping Luo; Huabin Li; Shuo Huang; Shuang Li; Weidong Zhao; Xuhong Zhou
Journal:  Biosci Rep       Date:  2018-07-31       Impact factor: 3.976

7.  A Nonsynonymous FCER1B SNP is Associated with Risk of Developing Allergic Rhinitis and with IgE Levels.

Authors:  Gemma Amo; Jesús García-Menaya; Paloma Campo; Concepción Cordobés; M Carmen Plaza Serón; Pedro Ayuso; Gara Esguevillas; Miguel Blanca; Jose A G Agúndez; Elena García-Martín
Journal:  Sci Rep       Date:  2016-01-21       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.